Neurology & Pain Management Coding Alert
Reader Question:
Get NF2 Dx Right the First Time
Published on Tue Mar 24, 2020
Question: Which ICD-10 code should I report for neurofibromatosis type 2? Alaska Subscriber Answer: You should report Q85.02 (Neurofibromatosis, type 2) for neurofibromatosis type 2. Neurofibromatosis type 2 is also called NF2 or central neurofibromatosis. This type of neurofibromatosis is characterized by bilateral acoustic neuromas, tumors of the vestibulocochlear nerve (8th Cranial nerve). The main complaint you should specifically look for in the clinical records is hearing loss. Other symptoms can include tinnitus (ringing in the ears) or poor balance.
Other Articles in this issue of
Neurology & Pain Management Coding Alert
- 2021 E/M Coding:
Time Has Come Today … to Prep for New E/M Rules
Here’s the 2 elements you’ll need to focus on moving forward. When a patient presents [...] - Injections:
Get the Scoop on New/Revised Intro/Injection Codes
You should never report 64416 in conjunction with this code. This year, the CPT® manual includes [...] - Interventional PM:
Prime Pain Pump, Injection Coding Knowledge
Interventional PM could involve several types of nerve blocks. Patients reporting to the PM practice [...] - You Be the Coder:
Coding Halstead–Reitan Tests
Question: My physician spent two hours with a patient administering the Halstead–Reitan Neuropsychological Battery assessment. This [...] - Reader Question:
Get NF2 Dx Right the First Time
Question: Which ICD-10 code should I report for neurofibromatosis type 2? Alaska Subscriber Answer: You [...] - Reader Question:
Return to OR Requires This Modifier
Question: Our physician removed an implanted pain pump and catheter from a patient whose pain [...]
View All
